0001837999-21-000001.txt : 20211119
0001837999-21-000001.hdr.sgml : 20211119
20211119094909
ACCESSION NUMBER: 0001837999-21-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
EFFECTIVENESS DATE: 20211119
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMvention Therapeutix, Inc.
CENTRAL INDEX KEY: 0001837999
IRS NUMBER: 822411198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384379
FILM NUMBER: 211426730
BUSINESS ADDRESS:
STREET 1: 701 W. MAIN STREET
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-593-6230
MAIL ADDRESS:
STREET 1: 701 W. MAIN STREET
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27701
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001837999
IMMvention Therapeutix, Inc.
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
919-593-6230
DELAWARE
None
None
Corporation
true
2017
Anil
Goyal
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Executive Officer
Director
Matthew
Cohen
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Director
Benjamin
Scruggs
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Director
Jenny
Ting
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Director
Lev
Osherovich
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Director
Mark
Vellaca
9 Laboratory Drive
Suite 264
RTP
NC
NORTH CAROLINA
27709
Director
Biotechnology
Decline to Disclose
- 06b
true
0001837999-20-000001
2020-12-07
true
true
false
0
6899999
6899999
0
false
5
0
0
0
true
false
IMMvention Therapeutix, Inc.
Anil Goyal
Anil Goyal
CEO
2021-11-19